<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="22966" whole_study_id="22966" phs="001457" v="1" p="1" createDate="2016-12-22T12:33:58-05:00" completedByGPADate="2017-01-04T16:15:44-05:00" modDate="2020-07-08T08:50:05-05:00" maxParentChildStudyModDate="2020-07-08T08:50:05-05:00" handle="AMP_RA" num_participants="58"><StudyInfo accession="phs001457.v1.p1" parentAccession="phs001457.v1.p1"><BioProject id="PRJNA407593" entrez_id="407593" type="bp_admin_access"/><BioProject id="PRJNA407594" entrez_id="407594" type="bp_data_submission"/><StudyNameEntrez>Accelerating Medicines Partnership-Rheumatoid Arthritis (AMP-RA)</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/><StudyType22 name="rnaseq_whole_targ_transcriptome"/></StudyType21><StudyType21 name="supporting_documents" chosen="Yes"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"/><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="rna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>individual_sequencing</StudyType><StudyType>supporting_documents</StudyType><StudyType>rna</StudyType><StudyType>whole_transcriptome</StudyType><StudyType>rna_seq_derived_expression</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/></StudyInfo><Authority><ICs><IC id="18" name="NIAMS" is_funding_ic="true" is_admin_ic="true" primary="true"/><IC id="5" name="NIAID" is_funding_ic="true" is_admin_ic="false"/></ICs><Persons><Person nedid="MAECKER" aid="2" auth="eRA" login="MAECKER" fname="Holden" mname="" lname="Maecker" email="maecker@stanford.edu"><Role allow_direct_access="true">PI</Role><Organization>STANFORD UNIVERSITY</Organization></Person><Person nedid="0010176105" aid="1" auth="cit" login="szteins" fname="Susana" mname="Alicia" lname="Serrate-Sztein" email="ss86e@nih.gov"><Role>PO</Role><Organization>NIH</Organization></Person><Person nedid="SOUMYARAYCHAUDHURI" aid="2" auth="eRA" login="SOUMYARAYCHAUDHURI" fname="Soumya" mname="" lname="Raychaudhuri" email="sraychaudhuri@bwh.harvard.edu"><Role>PI_ASSIST</Role><Organization>HARVARD MEDICAL SCHOOLBRIGHAM AND WOMEN'S HOSPITAL</Organization></Person><Person nedid="0010579723" aid="1" auth="cit" login="wewu" fname="Wenyu" mname="" lname="Wu" email="wwu@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="2001435773" aid="1" auth="cit" login="kirilushaag" fname="Anthony" mname="G" lname="Kirilusha" email="anthony.kirilusha@nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>This work was supported by the Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus Network. AMP is a public-private partnership (AbbVie Inc., Arthritis Foundation, Bristol-Myers Squibb Company, Lupus Foundation of America, Lupus Research Alliance, Merck Sharp &amp; Dohme Corp., National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Pfizer Inc., Rheumatology Research Foundation, Sanofi and Takeda Pharmaceuticals International, Inc.) created to develop new ways of identifying and validating promising biological targets for diagnostics and drug development. Funding was provided through grants from the National Institutes of Health (UH2-AR067676, UH2-AR067677, UH2-AR067679, UH2-AR067681, UH2-AR067685, UH2-AR067688, UH2-AR067689, UH2-AR067690, UH2-AR067691, UH2-AR067694, and UM2-AR067678).</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_by_timeout" gsr_mode_label="Unrestricted access (institution did not respond within six months)"/><ConsentGroup uid="2371" CGType="cg_class_HMB" title="Health/Medical/Biomedical" name="HMB" dac_uid="61" dac_name="NIAMS" irb-approval-required="No"><Use-Restriction>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.

</Use-Restriction></ConsentGroup><AdditionalEmails><Email>AMPRALupus@mail.nih.gov</Email></AdditionalEmails></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>